Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prime Medicine, Inc.

1.69
+0.330024.26%
Post-market: 1.68-0.0100-0.59%19:55 EDT
Volume:4.96M
Turnover:8.02M
Market Cap:216.02M
PE:-1.05
High:1.71
Open:1.42
Low:1.40
Close:1.36
Loading ...
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 01, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2024

Major Issues Report

Form 8-K - Current report
Feb 29, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 22, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Feb 16, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 06, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Correspondence

Form CORRESP - Correspondence
Nov 04, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
Aug 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities